Toronto Nanomedicine Gets Green Light for Cancer Clinical Trial

Tiny particles pack a big cancer-fighting punch.

A University of Toronto innovation in cancer nanomedicine has officially advanced to human trials, aiming to deliver chemotherapy while minimizing side effects precisely.

The therapy, developed over years of lab and preclinical work, uses nanoparticles designed to attack tumours more effectively than traditional methods.

“I believe the biggest potential for porphysomes is in minimally invasive treatments for early-stage cancers like early-stage lung cancer."

— Dr. Gang Zheng, Princess Margaret Cancer Centre, University Health Network, and University of Toronto’s Temerty Faculty of Medicine.

Read more →